Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

BrainStorm presents preclinical data on MSC-NTF exosomes in models of acute lung injury

Oct. 19, 2021

Boehringer Ingelheim exercises IP options to support development of gene therapy for cystic fibrosis

Oct. 19, 2021

Sichuan Haisco Pharmaceutical describes new JAK inhibitors

Oct. 8, 2021

Blade reports preclinical drug-drug interaction data on cudetaxestat for IPF

Sep. 21, 2021

SCN-16 targets the Keap1-Nrf2 protective pathway to treat ALI

Sep. 16, 2021

EPRS inhibitor DWN-12088 shows antifibrotic effects in vitro and in vivo

Sep. 15, 2021

PRS-220 shows favorable PK and biodistribution in fibrotic lung models

Sep. 13, 2021

GRC-39815 shows efficacy in models of smoke-induced COPD

Sep. 10, 2021

OR2AT4 identified as a new therapeutic target in COPD

Sep. 8, 2021

AI-driven discovery of novel candidates for idiopathic pulmonary fibrosis

Sep. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...